The emerging role of menin inhibitors in the treatment of NPM1-mutated and KMT2A-rearranged R/R AML
Amir Fathi • 6 Dec 2022
Promising agents in AML: menin inhibitors & magrolimab in TP53-mutated AML
Eytan Stein • 28 Sep 2022
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.